Investigations into the presence of PIK3CA mutations in pancreatic lesions have included studies examining intraductal papillary mucinous neoplasms (IPMNs), intraductal tubulopapillary neoplasm and invasive cancers. Here, PIK3CA is linked to pancreatic intraductal papillary-mucinous neoplasm.